
Overview
Background
Associate Professor Paul Griffin is the Director of Infectious Diseases at Mater Health Services in Brisbane and Associate Professor of Medicine at the University of Queensland Medical School. He has fellowships in Infectious Diseases from the Royal Australasian College of Physicians, in Clinical Microbiology from the Royal College of Pathologists of Australasia and from the Australasian College of Tropical Medicine.
Paul is the Principal Investigator and Medical Director at Nucleus Network, a specialized contract research organisation specializing in early and late phase trials in infectious diseases where he has been the principal investigator on in excess of 125 clinical trials, predominantly in Infectious Diseases including novel vaccines and Malaria human challenge studies. This includes 8 vaccines for COVID-19 and a number of COVID-19 therapies.
As a Clinical Microbiologist, he maintains an active interest in diagnostic microbiology with a focus on clinical applications of faecal microbiome metagenomic sequencing.
In addition to a teaching role at the University of Queensland, Paul is also the chair of the Advanced Training Committee in Infectious Diseases with the Royal Australasian College of Physicians, the committee that oversees the training of Infectious Diseases specialists in Australia.
Finally, as a director and scientific advisory board member of the immunisation coalition, Paul has an active interest in vaccine education and advocacy and has become a trusted media authority and spokesperson across the nation during the COVID-19 pandemic.
Availability
- Professor Paul Griffin is:
- Available for supervision
- Media expert
Fields of research
Research impacts
While performing vital clinical and research duties, he has also devoted time to inform, educate and reassure the community via a wide range of media appearances. He has featured regularly on prominent Australian programs across television, radio, print and online including The Project, Sunrise, Today Show, A Current Affair, and internationally including Canada’s CTV and the BBC.
Works
Search Professor Paul Griffin’s works on UQ eSpace
2013
Conference Publication
Rapid identification of VRE with MALDI-TOF MS
Griffin, Paul M., Price, Gareth R., Schooneveldt, Jacqueline M., Schlebusch, Sanmarié, Urbanski, Tess, Hamilton, Brett and Venter, Deon (2013). Rapid identification of VRE with MALDI-TOF MS. Australasian Division of the International Academy of Pathology 37th Annual Scientific Meeting 2012, Sydney, NSW Australia, 1-3 June 2012. London, United Kingdom: Elsevier. doi: 10.1097/01.pat.0000426852.32930.4a
2012
Journal Article
Chronic urticaria following acute hepatitis A
Griffin, Paul M., Kevat, Dev A. S., McCarthy, James S. and Woods, Marion L. (2012). Chronic urticaria following acute hepatitis A. BMJ case reports, 2012 (sep18 1), bcr2012006479-bcr2012006479. doi: 10.1136/bcr-2012-006479
2012
Journal Article
Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak
Griffin, Paul M., Price, Gareth R., Schooneveldt, Jacqueline M., Schlebusch, Sanmarie, Tilse, Martyn H., Urbanski, Tess, Hamilton, Brett and Venter, Deon (2012). Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak. Journal of Clinical Microbiology, 50 (9), 2918-2931. doi: 10.1128/JCM.01000-12
2011
Journal Article
A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs
McCarthy, James S., Sekuloski, Silvana, Griffin, Paul M., Elliott, Suzanne, Douglas, Nanette, Peatey, Chris, Rockett, Rebecca, O'Rourke, Peter, Marquart, Louise, Hermsen, Cornelius, Duparc, Stephan, Moehrle, Joerg, Trenholme, Katharine R. and Humberstone, Andrew J. (2011). A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS ONE, 6 (8) e21914, e21914-1-e21914-8. doi: 10.1371/journal.pone.0021914
2010
Journal Article
Malaria: Part 2
Griffin, Paul and McCarthy, James (2010). Malaria: Part 2. Medical Observer, 23-23.
2010
Journal Article
Malaria: Part 1
Griffin, Paul and McCarthy, James (2010). Malaria: Part 1. Medical Observer, 23-23.
2010
Book Chapter
Diloxanide furoate
Griffin, Paul M. (2010). Diloxanide furoate. Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral Drugs. (pp. 2121-2124) edited by M. Lindsay Grayson, Suzanne M. Crowe, James S. McCarthy, John Mills, Johan W. Mouton, S. Ragnar Norrby, David L. Paterson and Michael A. Pfaller. Boca Raton, FL, USA: CRC Press. doi: 10.1201/b13787-206
2010
Book Chapter
Niclosamide
Griffin, Paul M. and McCarthy, James (2010). Niclosamide. Kucers' the use of antibiotics: a clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs. (pp. 2293-2296) edited by M. Lindsay Grayson, Suzanne M. Crowe, James S. McCarthy, John Mills, Johan W. Mouton, S. Ragnar Norrby, David L. Paterson and Michael A. Pfaller. Boca Raton, FL, United States: CRC Press. doi: 10.1201/b13787-232
2010
Book Chapter
Furazolidone (furazolidine)
Griffin, Paul M. (2010). Furazolidone (furazolidine). Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral Drugs. (pp. 2114-2120) edited by M. Lindsay Grayson, Suzanne M. Crowe, James S. McCarthy, John Mills, Johan W. Mouton, S. Ragnar Norrby, David L. Paterson and Michael A. Pfaller. Boca Raton, FL, USA: CRC Press. doi: 10.1201/b13787-205
2005
Journal Article
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
Dorr, Patrick, Westby, Mike, Dobbs, Susan, Griffin, Paul, Irvine, Becky, Macartney, Malcolm, Mori, Julie, Rickett, Graham, Smith-Burchnell, Caroline, Napier, Carolyn, Webster, Rob, Armour, Duncan, Price, David, Stammen, Blanda, Wood, Anthony and Perros, Manos (2005). Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrobial Agents and Chemotherapy, 49 (11), 4721-4732. doi: 10.1128/AAC.49.11.4721-4732.2005
Funding
Past funding
Supervision
Availability
- Professor Paul Griffin is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
Contact Professor Paul Griffin directly for media enquiries about:
- COVID-19
- Infectious Diseases
- microbiology
- Vaccines
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: